Electronic fetal monitoring sits at the center of cerebral palsy litigation
For four decades, electronic fetal monitoring has remained the central mechanism around which cerebral palsy litigation has been built. The argument in this child neurology review is blunt: the device persists in labor rooms and courtrooms not because it has proved causation or prevention, but because it has acquired the appearance of medical authority despite a thin scientific base. The authors trace that persistence to childbirth myths inherited from the 19th century, a diagnostic practice with a very high false-positive rate, and an enduring legal culture that continues to treat abnormal tracings as if they reliably identify preventable brain injury.
One sentence captures the problem with unusual force: the monitoring technology has not lowered the incidence of cerebral palsy.
Instead, the review argues, it has contributed to a more aggressive delivery pattern, especially higher cesarean section rates, with all of the maternal and neonatal risks that can follow from surgical birth. That sequence matters clinically because a test with poor specificity can convert uncertainty into intervention. In obstetrics, false alarms do not stay theoretical; they can trigger operative delivery, expose mothers to surgical morbidity, and alter neonatal outcomes without changing the disease the test is presumed to prevent.
False-positive tracing meets legal certainty
The review’s central scientific critique is the claim that electronic fetal monitoring has a false positive rate exceeding 99%. In practical terms, that means the tracing is poor at distinguishing fetal compromise from normal labor variation. A test that often cries wolf is not merely imperfect; it is dangerous when its results are treated as proof of hypoxic injury. When those tracings enter malpractice litigation, the courtroom can assign causation to a pattern that may have little or no causal meaning.
The biological logic behind the critique is straightforward. Labor is a dynamic physiologic process, and fetal heart rate changes can reflect many transient conditions, not a single path toward permanent neurologic injury. If a method cannot reliably identify the fetuses actually at risk, it cannot credibly establish that a particular intrapartum event caused later cerebral palsy. Yet the review argues that courts and labor units have often continued to act as if the monitor provides that certainty.
The result is a feedback loop: the monitor is used, the trace is interpreted as ominous, intervention follows, and the legal system later uses the same strip as evidence that the injury was foreseeable and preventable. That is not a small evidentiary flaw. It changes how causation is argued in some of the most consequential cases in obstetric medicine.
Cesarean delivery rose while cerebral palsy did not fall
The authors place special emphasis on the mismatch between heavy monitoring use and the absence of any corresponding decline in cerebral palsy. If a technology were genuinely preventive, a long era of widespread adoption would be expected to produce at least some epidemiologic signal. The review says that signal is missing.
What did rise was the cesarean section rate. That increase carries its own cost profile: maternal hemorrhage, infection, thromboembolic complications, and downstream morbidity for both mother and baby. Even when cesarean delivery is lifesaving, a system that uses an over-sensitive surveillance tool can shift the balance toward more surgery without improving the target outcome. The review treats that tradeoff as a central reason why the long-standing faith in fetal monitoring deserves far sharper scrutiny.
Professional endorsement has helped preserve the practice. The authors argue that major organizations have failed to condemn the use of electronic fetal monitoring in courtroom arguments, allowing the technology to retain authority in both medicine and law even though its scientific support remains weak. In effect, institutional reluctance has allowed an unsound premise to survive through repetition.
Courtroom dependence has outlasted scientific credibility
The legal history described in the article is as important as the medical one. According to the review, attempts at tort reform, special cerebral palsy courts, and damage caps have not stopped the expansion of litigation. Those reforms may alter payout structure or procedure, but they do not directly confront the evidentiary claim that fetal monitoring proves preventable injury.
The authors argue that the answer lies in evidence law, specifically the Daubert doctrine, which excludes unreliable “junk science” from the courtroom. In their view, Daubert offers the most direct path to ending the use of fetal monitoring as pseudo-scientific proof of causation. The argument is not merely legal housekeeping. If a diagnostic method lacks the scientific validity to support causal inference, then admitting it as decisive evidence distorts both obstetric accountability and patient care.
A courtroom can turn a dubious tracing into a narrative of blame. Once that happens repeatedly, medical practice can be shaped by litigation fear rather than by reliable data.
Why the review remains provocative in obstetric medicine
This article is not a neutral description of a contested field; it is a direct challenge to a deeply embedded obstetric habit. The critique forces a hard question about why a modality with such poor predictive performance continued to dominate labor management for so long. The answer offered here is cultural as much as scientific: once a test becomes institutionally familiar, it can acquire credibility that exceeds its actual performance.
That dynamic helps explain why the monitor persists in two domains at once. In the delivery suite, it is treated as a signal of fetal safety or danger. In the courtroom, it becomes a record of what should have been predicted and prevented. The same strip is asked to do too much. It is used to guide interventions, assign blame, and support causal narratives that the underlying science cannot sustain.
For clinicians, the practical implication is severe. When a test has poor specificity and no proven impact on the incidence of cerebral palsy, its most predictable effect may be more intervention, not better prevention. For attorneys and judges, the implication is equally stark: a technology that appears precise on paper may still be scientifically unreliable in the context where it is most often wielded.
The review closes the circle by returning to the same point from a legal angle. If cerebral palsy litigation has continued for 40 years on the back of a monitoring technology with little scientific foundation, then the real controversy is not whether fetal heart rate tracing exists. It is whether the legal system should keep treating it as evidence of causation when medicine has never established that it can do that job.